|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical Research |
|
Wound Healing 1.
Title: Aim:
Summary:
This factor was first described in embryological development where it is involved in vessel growth. It is then only switched on when it is needed in adult life, during vessel growth after tissue damage (wound healing) but also in vessels growing in tumours. As vessel growth is needed for efficient wound healing it is of great interest to know how this factor works, particularly how it controls endothelial cell function (the cells that are responsible for small vessel growth). The possibility that it could be switched on when new vessels are needed, such as in wounds or switched off in situations where vessel growth is undesirable (such as in tumours) makes it a target molecule for future treatment of diseases where angiogenesis is implicated. |
Home
| Contact Us | Site
Map | Disclaimer |
Gallery
Copyright © 2001 - 2005 Sir Edward Dunlop Medical Research Foundation